Viusid and Asbrip

DIETARY_SUPPLEMENT2 trials

Sponsors

Catalysis SL

Conditions

COVID-19 PneumoniaCOVID-19 Respiratory InfectionCardiopathyCovid-19Covid19Diabete MellitusInfection, CoronavirusLiver Diseases

Phase 2

Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19

CompletedNCT04407182

Catalysis SLCardiopathy, Covid-19, Diabete Mellitus +4

Start: 2020-05-04End: 2020-10-01Updated: 2021-01-08

Unknown Phase

Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip

CompletedNCT04980534

Catalysis SLCovid19, COVID-19 Pneumonia, COVID-19 Respiratory Infection +4

Start: 2021-01-08End: 2021-09-15Updated: 2022-04-13